Dentifrice containing stabilized enzyme

Abstract

Stable oral compositions containing the enzyme dextranase, a mixed surfactant system of anionic and amphoteric surfactants, and a cationically modified hydrolyzed collagen stabilizer, which stabilizer the dextranase in the presence of the anionic surfactant without substantially reducing its foaming and cleansing properties.

Claims

What is claimed is: 1. A foaming, stable oral composition comprising a dextranase in an amount to provide 5,000 to 55,000 units/g of initial enzyme activity a mixed surfactant system consisting of at least one anionic surfactant and an amphoteric surfactant selected from the group consisting of a betaine and a sulfobetaine, in a molar ratio of 1:1 to 1:2 of anionic to amphoteric surfactant, and a cationically modified hydrolyzed collagen protein stabilizer in an effective amount to stabilize said enzyme activity and in the weight ratio of 1:1 to 1:2 anionic surfactant to protein stabilizer, in a dental vehicle, the combination of said amphoteric surfactant and said cationically modified protein stabilizer effective in stabilizing said enzyme activity against loss during aging and against inactivation due to the presence of the anionic surfactant. 2. An oral composition according to claim 1, wherein the said cationically modified stabilizer is a quaternary derivative of hydrolyzed protein. 3. An oral composition according to claim 1, wherein the cationically modified stabilizer constitutes about 1 to 5% by weight of the composition. 4. An oral composition according to claim 1, wherein the dextranase constitutes about 0.5 to 4% by weight of the composition. 5. An oral composition according to claim 1, wherein the anionic surfactant is sodium lauryl sulfate. 6. An oral composition according to claim 1, containing sodium lauryl sulfate and ammonium lauryl ether sulfate. 7. An oral composition according to claim 1, in the form of a toothpaste containing about 30-75% by weight of a water insoluble polishing agent. 8. An oral composition according to claim 1, in the form of a toothpowder containing about 70-80% water insoluble polishing agent. 9. An oral composition according to claim 1, in the form of an aqueous mouthwash containing about 5-10% ethanol. 10. An oral composition according to claim 1, in the form of a chewing gum, comprising about 20-35% of a gum base containing a natural or synthetic elastomer filler. 11. An oral composition according to claim 7, wherein the polishing agent is hydrated alumina. 12. An oral composition according to claim 7, wherein the polishing agent is dicalcium phosphate dihydrate. 13. An oral composition according to claim 7, wherein the polishing agent is silica. 14. A toothpaste according to claim 7, containing a liquid content of 20-75% by weight of the composition. 15. An oral composition according to claim 1, wherein the amphoteric surfactant has the general formula: ##STR5## wherein R 1 is an alkyl group having 10 to 20 carbon atoms, the amido radical: ##STR6## the amino radical: R--NH--(CH.sub.2).sub.a --, wherein R is an alkyl radical of 10 to 20 carbon atoms and a is an integer 1 to 3; R 2 and R 3 are each alkyl radicals having 1 to 3 carbons; and R 4 is an alkylene or hydroxyalkylene group having 1 to 4 carbon atoms, and constitutes about 2-6% by weight of the composition.
This application is a continuation of application Ser. No. 619,879, filed June 12, 1984, now abandoned. BACKGROUND AND PRIOR ART The present invention relates to novel dextranase-containing dentifrices which are enzymatically, physically and cosmetically stabilized in the presence of anionic surfactants by the addition of a dual anionic and amphoteric betaine surfactant system and a cationically modified hydrolyzed collagen protein stabilizer, to provide formula stability and retention of enzyme activity over time. The prior art is replete with information relating to the effectiveness of dextranase against dental plaque, its dispersion and removal, as shown in an article by Bowen in the British Dental Journal, vol. 24 number 8, pp. 347-349, (Apr. 16, 1968); an article by Fitzgerald et al, in JADA, vol. 76, pp. 301-304, (February 1968); and an article by Duany et al, in Journal of Preventive Dentistry, vol. 2, No. 2, pp. 23-27, (March-April 1975). The dextranase enzymes also reduce the formation of dental caries and periodontal disease when applied topically. These enzymes degrade or break down the dextrans synthesized in the plaque from sucrose by strep. mutans. The dextrans serve as a glue for the cohesion of the plaque. Accordingly, dextranase has been incorporated in conventional oral hygiene products such as toothpastes, rinses and chewing gum containing surface active cleansing and foaming agents, as shown in Japanese Patent Public Disclosure No. 56834/1973, and in British Patent No. 1,319,423 containing an anionic surfactant. These surfactants, especially anionic surfactants, tend to deactivate the enzymes such as dextranase, with rapid loss of enzyme activity in the absence of stabilization. Thus, it is difficult to make a stable and foaming dentifrice with dextranase. Accordingly, a number of stabilizers have been incorporated in dentifrice compositions containing dextranase. For example, U.S. Pat. No. 3,991,177 teaches the use of manganous and calcium ions to stabilize dextranases in the dentifrices in the presence of anionic surfactant such as sodium N-lauroyl sarcosinate. U.S. Pat. No. 3,981,989 discloses gelatin or peptone as the stabilizing agents for dextranases in the presence of sodium lauryl sulfate. U.S. Pat. No. 4,140,758 teaches the use of a metal ion selected from the group consisting of manganese, calcium, magnesium and mixtures thereof as a stabilizer/activator for dextranase. Japanese Patent No. 013318 by Lion, dated 2/6/1980, utilizes eugenol and 1-menthol as dextranase stabilizers in the presence of anionic surfactants. Japanese Patent No. 010350 by Lion Corp., dated 1/27/81, utilizes a mixture of dextranase and omega-amino acids in oral compositions to prevent bacterial plaque formation. French Patent Application No. 82/05799 discloses an oral composition comprising a mixture of dextranase and α-1,3 glucanase. U. K. Patent Application No. 2,061,727A utilizes aluminas and hydrated aluminas as the abrasive, in order to stabilize the dextranase in the dentifrice composition. U.S. Pat. No. 3,562,385 discloses dental antiplaque and anticalculus compositions containing a mixture of a bis-biguanido compound, dextranase and sodium hexametaphosphate. U.S. Pat. No. 3,622,661 discloses oral preparations containing dextranase and the specific binder Irish moss or gum tragacanth to prevent separation upon standing. Oral antiplaque and/or anticalculus compositions containing dextranase are also disclosed in U.S. Pat. Nos. 3,630,924; 3,686,393; and 3,751,561. Oral compositions containing dextranase in combination with other enzymes are disclosed in U.S. Pat. No. 4,335,101. Dextranase has been modified by molecular alteration by the use of a phosphoprotein carrier and a reacting agent such as ethylchloroformate, in order to provide longer periods of activity in the oral cavity, as disclosed in U.S. Pat. No. 4,138,476. Toothpastes having cosmetic and enzymatic stability containing a neutral protease of B. subtilis, stabilized by a partially hydrolyzed protein is disclosed in U.S. Pat. No. 4,058,596. The addition of a Group IIA metal ion to the neutral protease and hydrolyzed protein combination provides additional stability as disclosed in U.S. Pat. No. 4,058,595. Although the problem of stabilizing dextranase in the presence of anionic surfactants is well known in the prior art, and has been solved by the addition of a variety of stabilizing agents as aforecited, there is no disclosure of the use of a dual surfactant system of anionic surfactants and amphoteric betaine and a cationically modified hydrolyzed collagen protein stabilizer, such as a quaternized hydrolyzed protein (Crotein Q). SUMMARY OF THE INVENTION It has been unexpectedly found that the addition of a quaternized hydrolyzed collagen protein stabilizer to a dentifrice comprising a dextranase enzyme, and a dual surfactant system of an anionic surfactant and an amphoteric betaine, provides better shelf-life stability for the enzyme than gelatin and other prior art enzyme stabilizers, without adversely affecting the foaming power or detergency of the anionic surfactant. Accordingly, a primary object of present invention is to provide a stable dentifrice containing a dual surfactant system of an anionic surfactant and an amphoteric betaine, a dextranase enzyme and a quaternized hydrolyzed collagen protein stabilizer. Another object of present invention is to provide a foaming and stable dextranase-containing dentifrice in the presence of anionic and amphoteric surfactants. Still another object of present invention is to provide a physically and cosmetically stable dextranase-containing dentifrice with retention of enzyme activity over time. Additional objects, advantages and novel features of the invention will be set forth in part in the description which follows, and in part will become apparent to those skilled in the art upon examination of the following or may be learned by practice of the invention. The objects and advantages of the invention may be realized and attained by means of the instrumentalities and combinations particularly pointed out in the appended claims. To achieve the foregoing and other objects and in accordance with the present invention, as embodied and broadly described herein, the stable dentifrice of this invention comprises dextranase, a dual surfactant system of an anionic surfactant and an amphoteric betaine, in the molar ratio of 1:1 to 1:2 and preferably 1.2:1 respectively, and a cationically modified hydrolyzed collagen protein stabilizer, typically, a quaternary derivative of hydrolyzed protein, in a dental vehicle. In accordance with certain of its further aspects, the present invention relates to a stable oral composition, which may be in the form of a powder, paste, cream, liquid or chewing gum, comprising a dual surfactant system of an anionic surfactant and an amphoteric betaine in the molar ratio of 1.2:1 respectively, a dextranase in an amount to provide 5,000 to 55,000 units/g of initial enzyme activity, and a quaternized hydrolyzed collagen protein stabilizer in a weight ratio of 1:1 to 1:2 of anionic surfactant to the cationically modified hydrolyzed protein stabilizer. Dextranase enzymes are produced from a variety of sources all of which are useful in the present invention. Dextranase enzymes are commonly produced by growing Penicillium funiculosium or other fungal sources in a dextran-containing medium. The dextran is commonly a commercial grade obtained from Leuconostoc mesenterioides. This commercial grade of dextran contains about 95-percent α-1,6-glucoside linkages and about 5 percent α-1,3-glucoside linkages. The Penicillium organism produces the dextranase which particularly hydrolyzes the 1,6-linkages. Dextranase may also be prepared in accordance with procedures which are described in the art. These include the procedure described by Bowen, "British Dental Journal," Vol. 124, No. 8, dated Apr. 16, 1968, pages 343-349. A further procedure is described in U.S. Pat. No. 2,742,399 to Tsuchiya et al. (Note also Tsuchiya et al, "Journal of Bacteriology," Vol. 64, page 513). In the procedure of Bowen, dextran may be prepared from noncariogenic streptococcal strains such as ATCC 10558, 903-1600, IIA2+3, or Leuconostoc mesenterioides and purified according to the method described by Wood et al, "Archives of Oral Biology," Vol. 11, 1066, pages 1039 ct seq., except that L. mesenterioides is grown at 25° C. Dextranase may be prepared by inoculating Penicillium funicolosum into flasks containing 250 ml of a medium containing 0.5% yeast extract and 1% dextran. The flasks are incubated at 30° C. on a shaking incubator for 4 days. The culture is then centrifuged at 3,000 g for 20 minutes and filtered through Whatman 42 filter paper. Dialysis in 16 mm "Visking" tubing against deionized water and concentrating fifty fold by dialysis against polyethylene glycol (molecular weight 20,000) follows. The dextranase produced in accordance with this procedure has a molecular weight of about 200,000 to 275,000. If desired, the dextranase may be further purified by fractionation with ammonium sulfate. Additional procedures for preparing dextranase include that described in U.S. Pat. No. 2,742,399 to Tsuchiya et al. Dextranases of bacterial origin are also useful in the present compositions. Bacterial-origin dextranase may be prepared in the general manner in which enzymes are derived from bacteria. However, the preferred source of dextranase for the purposes of this invention is a mutant of Bacillus coagulans, NRRL B-3977 (Beckman dextranase catalogue #680000). Bacterial-origin dextranase may be obtained by the addition of α-1,3-dextran or a mixture of α-1,6-, α-1,3-, and α-1,4-dextrans. The bacterial strain may be innoculated into a shaker flask or fermentator for a period of 1 to 5 days at 25°-40° C. The sterile growth medias can consist of the aforementioned dextran or mutan combined with a mixture of carbohydrate (starch, glucose, sucrose, cellulose), nitrogeneous compounds (protein digest, gelatin, casein, ammonium salts), growth stimulators, (yeast extract, corn steep liquor, distiller's solubles), or minerals. Preservatives may be added and the enzyme decanted, filtered, or centrifuged to precipitate the cells (intracellular dextranase). The extracellular dextranase can be precipitated with ammonium sulfate, acetone, sodium sulfate, or a similar salt. The intracellular dextranases are autolyzed and extracted. Following the salt fractionation step, the enzyme can be further purified by a variety of column (DEAE, Sephodex, ECTEOLA, hydroxyapatite) chromatography methods and frozen or stabilized by the addition of protein, dextran, salt, etc. (The purification steps are usually conducted at refrigerated temperatures.) The amount of dextranase employed in the oral compositions of the invention is at least such amount as is effective in promoting oral hygiene. This amount is dependent upon the activity of the dextranase which may typically range from 5,000-55,000 units/g and therefore upon the mode of its preparation. A typically prepared dextranase enzyme material has an activity of about 10,000 units/g. Enzyme activity units are defined as the microgram (mg) of product formed (glucose) per minute per gram of dentifrice referred to a Glucose standard curve as set forth in the Journal of Bacteriology, Vol. 64(4), pages 513-514 (1952), which is more fully discussed hereinafter. While smaller amounts of dextranase may be used, dextranase having an activity of about 5,000-55,000 units/g may be present in amounts of about 0.5-4% by weight of the oral composition. The dentifrice of this invention preferably contains 5,000-55,000 units/g dentifrice of initial enzyme activity and exhibits physical and cosmetic stability and the retention of enzyme activity over time (at least 75% enzyme activity after 12 weeks of aging at 100° F.). It is essential that present dextranase-containing dentifrice comprise a dual surfactant system of an anionic surfactant and an amphoteric surfactant selected from the class consisting of betaines and sulfobetaines, in a molar ratio of about 1:1 to 1:2 respectively. An important consideration in the surfactant system is the molar ratio of sodium lauryl sulfate (SLS) to betaine, with the optimum being approximately 1.2 to 1 respectively. It is believed that the desirability of this ratio is due to the optimum establishment of a mixed micelle system helping to moderate the denaturing effect of the sodium lauryl sulfate. Increasing the betaine to an amount resulting in an SLS to betaine ratio of 1:2 or more produces a stable dentifrice with unsatisfactory taste characteristics. This surfactant system generates a stable foam and assists in achieving thorough and complete dispersion of the composition throughout the oral cavity. J. Garcia Dominguez, International Journal of Cosmetic Science, Volume 3, pp. 57-68 (1981), discloses that amphoteric betaine inhibits sodium lauryl sulfate from denaturing dextranase in an aqueous solution, by the formation of mixed micelles through ionic interaction with SLS. However, its use in a dentifrice together with the cationic protein stabilizer affords unexpected and unusual formula stability and the retention of enzyme activity upon aging. The anionic surface active agents contain a sulfonate, sulfate, carboxylate or phosphate as the anionic water solubilizing group. Examples of suitable anionic detergents include the soaps, such as the water soluble salts of higher fatty acids or rosin acids, such as may be derived from fats, oils and waxes of animal, vegetable or marine origin, e.g., the sodium soaps of tallow, grease, coconut oil, tall oil and mixtures thereof; and the sulfated and sulfonated synthetic detergents, particularly those having about 8-26, and preferably about 12-22, carbon atoms to the molecule. Examples of suitable synthetic anionic detergents include the higher alkyl mononuclear aromatic sulfonates such as the higher alkyl benzene sulfonates containing from 8-16 carbon atoms in the alkyl group in a straight or branched chain, e.g., the sodium salts of decyl, undecyl, dodecyl (lauryl), tridecyl, tetradecyl, pentadecyl, or hexadecyl benzene sulfonate and the C 8 -C 16 alkyl toluene, xylene and phenol sulfonates: C 8 -C 16 alkyl naphthalene sulfonate, ammonium diamyl naphthalene sulfonate, and sodium dinonyl naphthalene sulfonate; sulfated aliphatic alcohols such as sodium lauryl and hexadecyl sulfates, triethanolamine lauryl sulfate, and sodium oleyl sulfate; sulfated alcohol ethers, such as lauryl, tridecyl, or tetradecyl sulfates including 1-5 ethylene oxide moieties; ammonium lauryl ether sulfate; sulfated and sulfonated fatty oils, acids or esters, such as the sodium salts of sulfonated castor oil and sulfated red oil; sulfated hydroxyamides such as sulfated hydroxyethyl lauramide; sodium slat of lauryl sulfoacetate; sodium salt of dioctyl sulfosuccinate, the sodium salt of oleyl methyl tauride, and sodium N-lauryl sarcosinate. Also included within the ambit of the invention are the sulfuric acid esters of polyhydric alcohols incompletely esterified with higher fatty acids, e.g., coconut oil monoglyceride monosulfate, tallow diglyceride monosulfate; and the hydroxy sulfonated higher fatty acid esters such as the higher fatty acid esters of low molecular weight alkylol sulfonic acids, e.g., oleic acid ester of isethionic acid. The anionic surfactants most often used are the ammonium, mono-, di- and triethanolamine, and alkali metal (sodium and potassium) salts of the higher alkyl benzene sulfonates, the higher alkyl sulfates, the higher fatty acid monoglyceride sulfates and the sulfated ethoxylated alcohols, ammonium lauryl ether sulfate, sodium N-lauroyl sarcosinate, dioctyl sodium sulfosuccinate, and mixtures thereof. It is preferred to use the anionic surfactant in an amount of about 0.5 to 5% by weight of the carrier. The amphoteric surfactant, the other essential member of the dual surfactant system, has both anionic and cationic groups, is ionically balanced, and its isoelectric point is at a pH of about 7 and includes the betaines and sulfobetaines. The betaines are a class of amphoteric surfactants which include alkyl betaines, alkylamido betaines and alkylamino betaines having the general formula: ##STR1## wherein R 1 is an alkyl group having 10 to about 20 carbon atoms, preferably 12 to 16 carbon atoms or the amido radical: ##STR2## or an amino radical: R--NH--(CH.sub.2).sub.a -- wherein R is an alkyl group having about 10 to 20 carbon atoms and a is the integer 1 to 3; R 2 and R 3 are each alkyl groups having 1 to 3 carbons and preferably 1 carbon; R 4 is an alkylene or hydroxyalkylene group having from 1 to 4 carbon atoms and, optionally, one hydroxyl group. Typical alkyldimethyl betaines include decyl betaine or 2-(N-decyl-N,N-dimethylammonio) acetate, coco betaine or 2-(N-coco-N,N-dimethylammonio) acetate, myristyl betaine, palmityl betaine, lauryl betaine, cetyl betaine, stearyl betaine, etc. The amidobetaines similarly include cocoamidoethyl betaine, cocoamidopropyl betaine, lauramidopropyl betaine and the like. The sulfobetaines, which are similar in structure to the betaines, have sulfonate groups in place of the carboxylate groups, as represented by the general formula: ##STR3## wherein R 1 , R 2 , R 3 and R 4 have the same meanings as above, and include alkylsulfobetaines, alkylamidosulfobetaines and alkylaminosulfobetaines. The molar ratio of anionic to amphoteric surfactant of 1:1, 1.2:1 and up to 1:2, afford good dextranase stability in the presence of a polycationic stabilizer such as Crotein Q. It is preferred to use the amphoteric surface active agent in an amount of about 2-6% by weight of the carrier. The inactivation of the dextranase due to the presence of the anionic surfactant in the dentifrice makes it additionally necessary to add about 1-5% by weight of a cationic stabilizer, having multiple positive charges, to also interact with the anionic surfactant sodium lauryl sulfate (SLS), thereby reducing its ability to interact with the enzyme dextranase. The stabilizer is a cationically modified hydrolyzed collagen protein. More specifically, said stabilizer is a quaternary derivative of hydrolyzed collagen protein. The ratio of cationic stabilizer:anionic surfactant is within the weight range of about 1:1 to 2:1 respectively in order to assist in binding the anionic surfactant and prevent its interaction with dextranase. The quaternary derivative of hydrolyzed collagen protein is a product of Croda Inc. of New York, known as Crotein Q, having a minimum pI of 9.5-10.5, is an off-white free flowing powder and its adopted name is steartrimonium hydrolyzed animal protein. The free amino groups in the protein molecule react with the quaternary ammonium reactant to form the quaternized derivative which has multiple positive charges. At pH's below 5.5, Crotein Q will exhibit a double positive charge, due to protonation of NH groups in the protein chain, as shown diagrammatically in the Crodata circular 7778, page 2. Stability studies conducted on dextranase enzymes have shown that the enzyme inactivating effects of anionic surfactants such as sodium lauryl sulfate can be substantially decreased in the presence of an amphoteric surfactant such as betaine and a polycationic stabilizer, such as Crotein Q. Although the exact mechanism by which this combination of stabilizers effect this function is not known, it is hypothesized that both the Crotein Q and the betaine preferentially prevent the reaction of the enzyme with the anionic surfactants. The preferential interaction of the stabilizers with the anionic surfactant(s) prevents the anionic surfactant-inactivation of the dextranase. The stability of the dextranase-containing dentifrice is measured by the retention of enzyme activity over a protracted period of time as shown in Table I, wherein comparative samples of said dentifrice containing a dual surfactant system of anionic and amphoteric surfactant are used. The manual method of Tsuchiya et al, Journal of Bacteriology, Vol. 64 (4) pp. 513-514, (1952), is used to determine retention of enzyme activity and may be modified for the Technicon autoanalyzer, both using the colorimetric reagent dinitrosalicylic acid. Aged samples solubilized in water and buffer were incubated for 11.5 minutes with dextran substrate, the reaction stopped by boiling, the solution reacted with color reagent, and the absorbance read and compared to a glucose standard curve to determine the percent enzyme activity remaining. Despite inconsistencies in the enzyme activities detected for aged dentifrice samples which showed increasing activity with age, trends evidenced a gradual loss in dentrifice enzyme activity by the end of 12 weeks of aging at 100° F. In the case of some of the better formulations this was spot-checked and verified by manual analysis to be a loss of up to 30% at 12 weeks using the method described above. Examples 1-3 inclusive are more fully defined hereinafter. Examples 4-10 inclusive represent other stable dual surfactant dentifrice formulae utilizing conventional humectants, thickening agents, flavors and the like, in conventional amounts as set forth in this specification. TABLE I__________________________________________________________________________SLS/Betaine/Dextranase Formulations and Aging Data Initial % of Initial Enzyme ActivityEx. Ingredients Enzyme Activity 3 wks 6 wks 9 wks 12 wks__________________________________________________________________________1 3.6% Dextranase (0,83 mg 53,130 104 98 103 99 protein/ml), 2% Crotein Q, 1.8% SLS, 5% Betaine, Silica2 3.6% Dextranase (0.83 mg 49,392 100 98 87 79 protein/ml), 2% Crotein Q, 1.8% SLS, 5% Betaine, Alumina3 0.65% Dextranase (0.83 mg 5,340 0 0 0 0 protein/ml), 1% Crotein Q, 1.2% SLS, Alumina4 Alumina, 2% Crotein Q, 1.2% 4.570 110 101 95 83 SLS, 4% Betaine.sup.1, 0.55% Dextranase5 Silica, 2% Crotein Q, 1.2% SLS, 18,600 84 71 67 81 4% Betaine, 1% Amide, 2.1% Dextranase6 Alumina, 2% Crotein Q, 1.2% SLS, 13,800 99 88 107 107 4% Betaine, 1.8% Dextranase7 Alumina, 2% Crotein Q, 0.3% SLS, 13,400 91 95 116 113 0.9% ALES.sup.2, 4% Betaine, 1.8% Dextranase8 Alumina, 2% Crotein Q, 0.3% SLS, 27,000 103 99 123 121 0.9% ALES, 4% Betaine, 3.6% Dextranase9 Silica, 2% Crotein Q, 0.3% SLS, 28,300 102 99 120 119 0.9% ALES, 4% Betaine, 3.6% Dextranase10 Alumina, 3% Crotein Q, 1.2% SLS, 23,200 104 141 139 148 5% Betaine, 3.6% Dextranase__________________________________________________________________________ .sup.1 Sulfated amidobetaine .sup.2 Ammonium laurylether sulfate (60% active) Samples were aged at 100° F. Activities determined by colorimetric spectrophotometry using 3,5 dinitrosalicylic acid. Calculations: SLS (94% active, F.W. 288.38) 18 grams × 0.94 = 16.9 g = 0.0587 moles Betaine (27% active, F.W. 283) 50 grams × 0.27 = 13.5 g = 0.0477 moles ALES (60% active, F.W. 432) Molar ratio SLS: Betaine = 0.06:0.05 = 1.2:1 A molar ratio of about 1:1 or 1.2:1 between anionic and amphoteric is best, perhaps due to the formation of a mixed micelle solution of anionic/amphoteric whereby the SLS is prevented from denaturing the dextranase enzyme. Deletion of the betaine causes the dentifrice to rapidly lose its enzyme activity with aging as shown below: ______________________________________ Enzyme ActivityIngredients Molar ratio Recovery @ 12 weeks______________________________________1.2% SLS, 4% betaine 1.2:1 110%1.5% SLS, no betaine -- 0%______________________________________ The interactions of both stabilizers with the anionic surfactant to prevent its interaction with dextranase does not substantially reduce the foaming ability of the anionic agent. The foaming properties of the surfactants were measured according to standard foam height procedure. This analysis was conducted at 37° C. in both distilled and hard water (105 ppm CaCl 2 , and 70 ppm MgCl 2 ). Solutions were prepared to contain singularly or combinations of 0.1% SLS, or 1% betaine and/or 0.2% Crotein Q. Foam volume was measured in ml after 30 inversions of the graduate cylinder. The following graph shows the relative foam volumes in distilled water and hard water. ##STR4## This data shows that in distilled water, SLS produces the largest volume of foam. Those combinations containing SLS and Crotein foamed better than the combination of SLS and betaine, Crotein and betaine, and betaine alone. It is also noted that Crotein does not readily reduce SLS foaming although betaine does. In the hard water, foaming of SLS is drastically reduced, whereas foaming by betaine is unchanged. In hard water, foaming by SLS is greatly enhanced by the stabilizer Crotein. Overall, these results indicate that the system providing optimal enzyme stabilization, SLS+Crotein+betaine exhibits good foaming characteristics regardless of the water hardness. This point is important since the divalent cation concentration in the oral cavity is quite high. Accelerated aging studies further show that enzymatically, physically and cosmetically stable dentifrices containing approximately 5,000 units of dextranase per gram of dentifrice exhibit good foaming in the presence of betaine, and anionic surfactants and the cationic stabilizer as shown in Table II. TABLE II______________________________________ % of initial Aged Exzyme at *Height ofSample Ingredients Activity 100° F. Foam (ml)______________________________________1 Alumina - 1.2% 95 9 wks 54 Betaine, 1.2% SLS, 2% Crotein Q2 Alumina - 0.9% 96 9 wks 34 Betaine, 0.8% SLS, 1% Crotein Q3 Alumina - 1.2% 98 9 wks 30 Betaine, 0.6% SLS, 1% Crotein Q4 Silica - 1.2% 104 6 wks 32 Betaine, 0.6% SLS, 2% Crotein Q5 Alumina - 1.2% 83 9 wks 35 Betaine, 0.6% SLS, -6 Alumina - 1.2% 89 9 wks 32 Betaine, 0.5% SLS, -______________________________________ *The height of foam was measured after shaking 1 gram of dentifrice in 10 ml of 175 PPM hard water (90° F.) for 15 sec. Toothpastes and toothpowders conventionally contain a substantially water insoluble polishing agent or abrasive which is compatible with the formulation. Preferred compatible materials which do not adversely affect the dentifrice composition include dicalcium phosphate dihydrate, silica and hydrated alumina. The polishing agent may be the sole carrier material as in a toothpowder, and is present in an amount up to about 80% of the carrier and generally about 30-75% of the carrier. In toothpaste formulations the liquids and solids should necessarily be proportioned to form a creamy mass having the desired consistency which is extrudable from a pressurized container or a collapsible tube (for example, aluminum or lead). In general, the liquids in the toothpaste will comprise chiefly water, glycerin, aqueous solutions of sorbitol, propylene glycol, polyethylene glycol 400, etc., and suitable mixtures thereof. It is advantageous usually to use a mixture of both water and a humectant or binder such as glycerin or sorbitol. The total liquid content will generally be about 20-75% of the carrier. The amount of water is generally about 10-25% of the carrier. It is preferred to also use a gelling agent in toothpastes such as the natural and synthetic gums and gum-like materials such as Irish moss, gum tragacanth, carboxymethyl cellulose, Viscarin GMC, Iota carrageenan, starch, sodium alginate, and the like, usually in an amount up to about 10%, and preferably about 0.2-5%, of the carrier. The carrier suitably may contain a fluorine-containing compound having a beneficial effect on the care and hygiene of the oral cavity, for example, diminution of enamel solubility in acid and protection of the teeth against decay. Examples thereof include stannous fluoride, potassium stannous fluoride, sodium hexafluorostannate, stannous chlorofluoride, sodium fluorozirconate, and sodium monofluorophosphate. These materials, which dissociate or release fluorine containing ions in water, suitably may be present in the carrier in an effective but nontoxic amount, usually within the range of about 0.1-5% by weight. Various other materials may also be incorporated into the carrier. Examples thereof are coloring or whitening agents (for example, titanium dioxide), preservatives (for example, sodium benzoate), silicones, chlorophyll compounds, ammoniated materials such as urea, diammonium phosphate, and mixtures thereof, alcohol, menthol, and other constituents. These adjuvants are incorporated into the instant compositions in amounts which do not substantially adversely affect the properties and characteristics and are suitably selected and used in proper amount depending upon the particular type of preparations involved. Flavoring or sweetening materials of the type commonly employed in dentifrices may be included in the carrier. Such materials, if present, aid in modifying the particular tastes of the flavor in the manner desired. Examples of such additional materials include the flavoring oils, for example, oils of spearmint, peppermint, wintergreen, sassafras, clove, sage, eucalyptus, marjoram, cinnamon, lemon, and orange, as well as methylsalicylate. Suitable sweetening agents include sucrose, lactose, maltose, sorbitol, sodium cyclamate, and saccharin. Suitably, the flavor and sweetening agent may together comprise about 0.01-2% of the carrier. The dentifrice may be prepared by suitably mixing the ingredients. For instance in making a toothpaste, a gelling agent such as sodium carboxymethyl cellulose or Iota carrageenan and a preservative such as sodium benzoate, if employed, is dispersed in a humectant such as glycerin. Water may also be present. Additional humectant and water may then be mixed with the dispersion and a homogeneous paste, gel or cream is formed. Dental abrasive agent, surface active agents and flavor are then added. The toothpaste is then thoroughly deaerated (e.g., in vacuo) and tubed. The formulation may be deaerated during mixing or after mixing. DETAILED DESCRIPTION OF THE INVENTION The following examples are merely illustrative of the invention, but it is understood that the invention is not limited thereto. All amounts of various ingredients are by weight unless otherwise specified. EXAMPLE 1 ______________________________________Gel ToothpasteIngredients %______________________________________Glycerine 25CMC.sup.1 0.35Na Benzoate 0.5Na Saccharin 0.2Sodium Monofluorophosphate (MFP) 0.76Sorbitol 24.09Carbowax - PEG 600.sup.2 3FDC Blue #1 @ 1% 0.1Deionized water 6.6Silica containing combined alumina.sup.3 18Colloidal silica aerogel.sup.4 8Sodium lauryl sulfate (SLS) 1.8Betaine tego-S-1066.sup.5 5Crotein Q 2Flavor 1Dextranase (20,000 units/g) 3.6pH 6.5Foam 84 ml______________________________________ .sup.1 Carboxymethyl cellulose .sup.2 Polyethylene glycol, mol. weight 600 .sup.3 Zeo 49B, ex J. M. Huber .sup.4 Syloid 244 .sup.5 A sulfated amphoteric surfactant manufactured by Goldschmidt Chemical Corp., Actives 27% EXAMPLE 2 ______________________________________ToothpasteIngredients %______________________________________Iota carrageenan 0.9Glycerine 22Na Benzoate 0.5Na Saccharin 0.2MFP 0.76Deionized water 12.24Hydrated alumina 50SLS 1.8Sulfated amidobetaine (1.5% active) 5Crotein Q 2Flavor 1Dextranase (20,000 units/g) 3.6pH 7.41Foam 83 ml______________________________________ EXAMPLE 3 ______________________________________ToothpasteIngredients %______________________________________Iota carrageenan 0.9Glycerin 22Na Saccharin 0.2Methyl Paraben 0.1MFP 0.76Crotein Q 1Deionized water 23.19Hydrated alumina 50SLS 1.2Dextranase (20,000 units/g) 0.65pH 8.08______________________________________ The omission of the betaine reduces the enzyme stability of this composition to zero. EXAMPLE 4 ______________________________________ToothpasteIngredients %______________________________________Iota carrageenan 0.9Glycerin 22.0MFP 0.76Na Benzoate 0.5Na Saccharin 0.2Hydrated alumina 50SLS 1.2Betaine 4.0Crotein Q 2Flavor 1Dextranase (10,000 units/g) 1.8Deionized water 15.64pH 7.44Foam 58 ml______________________________________ EXAMPLE 5 ______________________________________ToothpasteIngredients %______________________________________Iota carrageenan 0.9Glycerin 22Na Benzoate 0.5No Saccharin 0.2MFP 0.76Hydrated alumina 50Deionized water 13.64SLS 1.2Betaine tego-S 1066 5Crotein Q 3Flavor 1Dextranase (10,000 units/g) 1.8pH 7.17Foam 71 ml______________________________________ EXAMPLE 6 ______________________________________ToothpasteIngredients %______________________________________Iota carrageenan 0.9Glycerin 22Na Benzoate 0.5No Saccharin 0.2MFP 0.76Hydrated alumina 50Deionized water 11.84SLS 1.2Betaine 5Crotein Q 3Flavor 1Dextranase (20,000 units/g) 3.6pH 7.28Foam 60 ml______________________________________ EXAMPLE 7 ______________________________________MouthwashIngredients %______________________________________Ethanol (90%) 5-10Glycerin 10-20Sodium Saccharin 0-5Sodium Benzoate 0-5Betaine 1-2Dextranase (5,000-20,000 units/ml) 0.05-1Sodium Lauryl Sulfate (SLS) 0.1-0.5Crotein Q 0.5-3Flavoring 0.22-0.5Water Q.S.______________________________________ EXAMPLE 8 ______________________________________ToothpowderIngredients %______________________________________Hydrated alumina 70-80Glycerin 10SLS 0.1-0.5Betaine 0.5-1.0Sodium Saccharin 0.1Flavoring 1.0Dextranase 5,000-20,000 units/gCrotein Q 0.5-3Water Q.S.______________________________________ EXAMPLE 9 ______________________________________Chewing GumIngredients %______________________________________Gum base (Natural or Synthetic 20-35elastomer filler i.e. gum arabic)Sorbitol 10-20Dextranase (5,000-20,000 units/g) 0.1-1Sodium Lauryl Sulfate 0.1-0.5Betaine 0.5-1Crotein Q 0.5-3Flavoring 0.5-2Dextrose Q.S.______________________________________ The following Table defines additional dextranase-containing dentifrice formulations having physical and cosmetic stability and the retention of enzyme activity upon aging. Examples 10-18 inclusive comprise an aqueous vehicle containing a suitable flavor material. Examples 10-13 inclusive contain 1.8% dextranase. Example 14 contains 2.1%, Example 15 contains 2.5% and Examples 16-18 inclusive contain 3.6% dextranase. Conventional humectants or mixtures thereof in suitable amounts as defined in this specification, are utilized. Examples 10, 11, 13, 16 and 18 comprise glycerin, whereas Examples 12, 14, 15 and 17 comprise a mixture of glycerin and sorbitol. __________________________________________________________________________EXAMPLES 10-18Toothpastes Initial Enzyme Activity AfterEx. Ingredients Foam (ml) Activity (units) 12 Weeks @ 100° F. % of Initial__________________________________________________________________________10 Iota*/Alumina, 1.2% SLS, 4% Betaine 58 13,800 15,200 110 2% Crotein Q11 Iota/Alumina, 3% SLS, 0.9% ALES, 58 13,400 15,100 113 4% Betaine, 2% Crotein Q12 Silica, 0.3% SLS, 0.9% ALES, 46 14,000 15,800 113 4% Betaine, 2% Crotein Q13 Iota/Alumina, 1.2% SLS, 5% Betaine, 71 12,500 16,100 129 3% Crotein Q14 Silica, 1.2% SLS, 4% Betaine, 55 18,600 15,000 81 2% Crotein Q, 1% Amide15 Silica, 0.6% SLS, 4% Betaine, 37 23,800 18,700 79 2% Crotein Q, 1% Amide16 Iota/Alumina, 0.3% SLS, 0.9% ALES, 50 27,000 32,700 121 4% Betaine, 2% Crotein Q17 Silica, 0.3% SLS, 0.9% ALES, 51 28,300 33,800 119 4% Betaine, 2% Crotein Q18 Iota/Alumina, 1.2% SLS, 5% Betaine, 60 23,200 34,300 148 3% Crotein Q__________________________________________________________________________ *Carrageenan Variations in the above formulations may be made. For example, other anionic surfactants such as higher alkyl benzene sulfonates, fatty acid soaps such as tallow soap, sulfated alcohol ethers and the like may be substituted for the specific anionic surfactants in the examples. Similarly, other betaines and sulfated betaines may be substituted for the specific betaine surfactants in the examples. Other thickening or gelling agents may be substituted for carboxymethyl cellulose or carrageenan such as starch, Irish moss, gum tragacanth and the like. It is understood that the foregoing detailed description is given merely by way of illustration and that variations may be made therein without departing from the spirit of the invention. The "Abstract" given above is merely for the convenience of technical searchers and is not to be given any weight with respect to the scope of the invention.

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (5)

    Publication numberPublication dateAssigneeTitle
    GB-1270200-AApril 12, 1972Blendax Werke Schneider CoTooth-cleaning compositions
    US-3957967-AMay 18, 1976Blendax-Werke R. Schneider & Co.Agent for the care and the cleaning of teeth and dentures
    US-3981989-ASeptember 21, 1976The Lion Dentifrice Co., Ltd.Oral preparation
    US-4391798-AJuly 05, 1983Colgate-Palmolive CompanyNon-irritating dentifrice
    US-4466954-AAugust 21, 1984Lion CorporationOral composition

NO-Patent Citations (0)

    Title

Cited By (93)

    Publication numberPublication dateAssigneeTitle
    WO-2015112671-A1July 30, 2015The Procter & Gamble CompanyConsumer product compositions
    US-5320831-AJune 14, 1994The Procter & Gamble CompanyOral compositions
    US-5560905-AOctober 01, 1996The Proctor & Gamble CompanyOral compositions
    US-2007028336-P1February 01, 2007Syngenta Seeds B.V.Ageratum plant named 'agbic'
    WO-2014062879-A2April 24, 2014The Procter & Gamble CompanyBandelette servant à l'administration d'un principe actif pour soins d'hygiène buccale et méthodes d'utilisation de principes actifs pour soins d'hygiène buccale
    US-2004042977-A1March 04, 2004Malcolm Williams, Michael Prencipe, Masters James G.Dual component dental composition containing enzyme
    US-2009202455-A1August 13, 2009Colgate-Palmolive CompanyOral care product and methods of use and manufacture thereof
    WO-2009100265-A2August 13, 2009Colgate-Palmolive CompanyCompositions and methods for the treatment of xerostomia
    US-8765155-B2July 01, 2014Colgate-Palmolive CompanyOral care strip or tape and methods of use and manufacture thereof
    US-5431903-AJuly 11, 1995The Procter & Gamble CompanyOral compositions
    US-5747005-AMay 05, 1998Barels; Ronald R., Cohler; Charles M.Oil-based, anti-plaque dentifrice composition
    US-5320830-AJune 14, 1994The Procter & Gamble CompanyOral compositions
    US-5849268-ADecember 15, 1998The Procter & Gamble CompanyOral compositions
    US-8821854-B2September 02, 2014Ganeden Biotech, Inc.Methods for inhibiting microbial infections associated with sanitary products and for enhancing sanitary product degradation
    US-8647648-B2February 11, 2014Colgate-Palmolive CompanyColor changing consumer products
    US-5126135-AJune 30, 1992Japan Fine Chemical Co., Ltd.Dermatological composition based on an aqueous phase
    US-2009060958-A1March 05, 2009Mello Sarita V, Arvanitidou Evangelia SOral care strip or tape and methods of use and manufacture thereof
    US-7939306-B2May 10, 2011Colgate-Palmolive CompanyAntibacterial dentifrice exhibiting antiplaque and breath freshening properties
    WO-2012064341-A1May 18, 2012Colgate-Palmolive CompanyProduit de soin buccal et procédés d'utilisation et de fabrication de celui-ci
    US-9855288-B2January 02, 2018Mannatech, IncorporatedProcessing of natural polysaccharides by selected non-pathogenic microorganisms and methods of making and using the same
    US-5578294-ANovember 26, 1996The Procter & Gamble CompanyOral compositions
    US-2011052509-A1March 03, 2011Colgate-Palmolive CompanyCompositions comprising basic amino acid and soluble carbonate salt
    US-2007183986-A1August 09, 2007Ultradent Products, Inc.Methods and systems for mixing a multi-part fluoride varnish composition
    US-5849271-ADecember 15, 1998The Procter & Gamble CompanyOral compositions
    WO-2009100263-A2August 13, 2009Colgate-Palmolive CompanyProduit de soins bucco-dentaires et méthodes d'utilisation et de fabrication dudit produit
    WO-2009100279-A2August 13, 2009Colgate-Palmolive CompanyCompositions contenant un acide aminé basique et un sel de type carbonate soluble
    US-2010307935-A1December 09, 2010Ultradent Products, Inc.Syringe-in-syringe hollow inner barrel/plunger with integral seal and rupturable membrane and related kits, systems, and methods
    US-2009202456-A1August 13, 2009Colgate-Palmolive CompanyNovel salts and their uses
    US-8454558-B2June 04, 2013Ultradent Products, Inc.Syringe-in-syringe hollow inner barrel/plunger with integral seal and rupturable membrane and related kits, systems and methods
    WO-2013089735-A1June 20, 2013Colgate-Palmolive CompanyOral care compositions
    WO-2010114551-A1October 07, 2010Colgate-Palmolive CompanyProduits de consommation à changement de couleur
    WO-2013089761-A1June 20, 2013Colgate-Palmolive CompanyColor changing compositions
    WO-2009140577-A1November 19, 2009Colgate-Palmolive CompanyOral compositions and uses thereof
    US-2010330002-A1December 30, 2010Colgate-Palmolive CompanyCompositions and methods comprising basic amino acid peptides and proteases
    US-8383163-B2February 26, 2013Ultradent Products, Inc.Fluoride varnish compositions including an organo phosphoric acid adhesion promoting agent
    US-2011189110-A1August 04, 2011Colgate-Palmolive CompanyCompositions and methods for the treatment of xerostomia
    US-2009186057-A1July 23, 2009Ganeden Biotech, IncorporatedTopical Use of Probiotic Bacillus Spores to Prevent or Control Microbial Infections
    EP-2384740-A2November 09, 2011Colgate-Palmolive CompanyMundpflegeprodukt und Verfahren zu dessen Verwendung und Herstellung
    US-5437856-AAugust 01, 1995The Procter & Gamble CompanyOral compositions
    US-2010266514-A9October 21, 2010Colgate-Palmolive CompanyDual Component Dental Composition Containing Enzyme
    US-2009202450-A1August 13, 2009Colgate-Palmolive CompanyOral care product and methods of use and manufacture thereof
    US-2010255044-A1October 07, 2010Susan Daly, Janusz Jachowicz, Robert Bianchini, Allwyn ColacoMethod of depositing particulate benefit agents on keratin-containing substrates
    WO-2009029352-A1March 05, 2009Colgate-Palmolive CompanyPellicules-fraîcheur et leurs procédés d'utilisation et de fabrication
    US-5292502-AMarch 08, 1994Colgate-Palmolive Co.Non-irritating dentifrice
    US-2006029554-A1February 09, 2006Malcolm Williams, Michael Prencipe, Masters James GDual component dental composition containing enzyme
    US-5620679-AApril 15, 1997The Procter & Gamble CompanyOral compositions
    US-9579269-B2February 28, 2017Colgate-Palmolive CompanyTherapeutic oral composition
    WO-2010114548-A1October 07, 2010Colgate-Palmolive CompanyOral care compositions comprising tetrapotassium pyrophosphate
    WO-2012057739-A1May 03, 2012Colgate-Palmolive CompanyComposition d'hygiène buccale comprenant de l'arginine et du carbonate de calcium
    US-9561168-B2February 07, 2017Colgate-Palmolive CompanyOral care compositions
    US-8399220-B2March 19, 2013Forsyth Dental Infirmary For ChildrenAntibacterial compositions
    WO-2012023936-A1February 23, 2012Colgate-Palmolive CompanyOral care product and methods of use and manufacture thereof
    US-9522111-B2December 20, 2016Colgate-Palmolive CompanyColor changing compositions
    WO-03041667-A2May 22, 2003The Procter & Gamble CompanyCompositions contenant des enzymes stabilisees a l'aide de certains osmoprotecteurs et methodes d'utilisation de ces compositions dans des soins d'hygiene personnelle
    US-8394052-B2March 12, 2013Ultradent Products, Inc.Syringe-in-syringe hollow inner barrel/plunger with integral seal and rupturable membrane and related kits, systems, and methods
    US-2007122357-A1May 31, 2007The Procter & Gamble CompanyDentifrice composition
    US-9271906-B2March 01, 2016Colgate-Palmolive CompanyOral compositions containing microaggregates
    EP-2384739-A2November 09, 2011Colgate-Palmolive CompanyOral care product and methods of use and manufacture thereof
    WO-2009100269-A2August 13, 2009Colgate-Palmolive CompanyProduit d'hygiène buccale et procédés d'utilisation et de fabrication correspondants
    US-9717929-B2August 01, 2017Colgate-Palmolive CompanyDentifrice compositions containing calcium silicate and a basic amino acid
    US-8852561-B2October 07, 2014Ultradent Products, Inc.Fluoride varnish compositions including an organo phosphoric acid adhesion promoting agent
    US-9138384-B2September 22, 2015Colgate-Palmolive CompanyColor changing consumer products
    US-9724278-B2August 08, 2017Colgate-Palmolive CompanyOral compositions and uses thereof
    WO-03041667-A3July 31, 2003Procter & GambleCompositions contenant des enzymes stabilisees a l'aide de certains osmoprotecteurs et methodes d'utilisation de ces compositions dans des soins d'hygiene personnelle
    US-2008213195-A1September 04, 2008Szeles Lori H, Xiaoyan Liu, Malcolm Williams, Masters James GAntibacterial Dentifrice Exhibiting Antiplaque and Breath Freshening Properties
    US-2009311200-A1December 17, 2009Colgate-PalmoliveOral Compositions and Uses Thereof
    US-7507402-B1March 24, 2009Ganeden Biotech, Inc.Topical use of probiotic Bacillus spores to prevent or control microbial infections
    WO-2012064339-A1May 18, 2012Colgate-Palmolive CompanyProduit de soin buccal et procédés d'utilisation et de fabrication de celui-ci
    US-9682026-B2June 20, 2017Colgate-Palmolive CompanyOral care product and methods of use and manufacture thereof
    US-2009202454-A1August 13, 2009Colgate-Palmolive CompanyOral care product and methods of use and manufacture thereof
    US-9408794-B2August 09, 2016Colgate-Palmolive CompanyOral care product and methods of use and manufacture thereof
    WO-2009100264-A2August 13, 2009Colgate-Palmolive CompanyProduit de soins bucco-dentaires et méthodes d'utilisation dudit produit
    US-8802105-B2August 12, 2014Forsyth Dental Infirmary For ChildrenAntibacterial compositions
    US-9220577-B2December 29, 2015Ultradent Products, Inc.Syringe-to-syringe mixing systems and related apparatus and methods
    US-5622689-AApril 22, 1997The Procter & Gamble CompanyOral compositions
    JP-2010275272-ADecember 09, 2010Lion Corp, ライオン株式会社歯磨剤組成物
    US-2006177429-A1August 10, 2006Sean Farmer, Lefkowitz Andrew RMethods for inhibiting microbial infections associated with sanitary products and for enhancing sanitary product degradation, systems and compositions
    EP-2700396-A2February 26, 2014Sylphar NvBande pour l'administration de compositions pour soins buccaux
    US-2009191279-A1July 30, 2009Ultradent Products, Inc.Fluoride varnish compositions including an organo phosphoric acid adhesion promoting agent
    WO-9847374-A1October 29, 1998Ganeden Biotech, Inc.Topical use of probiotic bacillus spores to prevent or control microbial infections
    US-6927053-B2August 09, 2005Colgate-Palmolive CompanyDual component dental composition containing enzyme
    US-2010330001-A1December 30, 2010Toshihisa Kawai, Stashonko Phllip P, Yoshiaka Hosokawa, Kazuhisa OharaAntibacterial compositions
    US-2008152601-A1June 26, 2008Colgate-Palmolive CompanyDual Component Dental Composition Containing Enzyme
    US-9622962-B2April 18, 2017Colgate-Palmolive CompanyOral care product and methods of use and manufacture thereof
    US-2011274676-A1November 10, 2011Sean Farmer, Mikhail Robert JTopical Use Of Probiotic Bacillus Spores To Prevent Or Control Microbial Infections
    WO-2012064338-A1May 18, 2012Colgate-Palmolive CompanyProduit de soin buccal et procédés d'utilisation et de fabrication de celui-ci
    US-2003157088-A1August 21, 2003The Proctor & Gamble CompanyCompositions containing enzymes stabilized with inhibitors having certain binding properties and methods for using such compositions in personal care
    US-9376722-B2June 28, 2016Colgate-Palmolive CompanyOral care methods and systems
    EP-3100716-A1December 07, 2016Colgate-Palmolive CompanyNeuartige salze und deren verwendungen
    WO-2009100260-A2August 13, 2009Colgate-Palmolive CompanyCompositions et procédés comprenant des peptides d'acides aminés basiques et des protéases
    US-2011085990-A1April 14, 2011Colgate-Palmolive CompanyOral care methods and systems
    WO-2012064319-A1May 18, 2012Colgate-Palmolive CompanyCompositions orales contenant des micro-agrégats
    EP-2172187-A1April 07, 2010Colgate-Palmolive CompanyDual component dental composition containing enzyme